Comparative Multicentre Study of a Panel of Thyroid Tests Using Different Automated Immunoassay Platforms and Specimens at High Risk of Antibody Interference
-
Julie Martel
Abstract
The introduction of automation for immunoassays in recent years has brought about important and evident improvements in assay precision. Increasing standardization and comparability between platforms should enable the development of clinical guidelines and diagnostic algorithms for appropriate clinical decision making. A continuing source of variation between different automated immunoassay platforms is the sporadic effect of interfering antibodies or substances, thus causing aberrant results not supporting the patient's clinical status.
The aim of this study was to describe current thyroid panel variation between automated immunoassay platforms including population specimens at risk of antibody interference. A multisite design with laboratories in three different countries using four different automated immunoassay platforms (Roche-Boehringer Mannheim Elecsys® (Italy), Roche-Boehringer Mannheim ES300® (Wales), Bayer Immuno 1® and the Bayer ACS:180® evaluated the thyroid panel of thyrotropin (TSH), triiodothyromine (T3), free thryroxine (FT4) and free triiodothyronine (FT3). A common set of 158 randomly selected patient samples of non-thyroid and thyroid disorders, with and without treatment, was tested. Included were 62 patient samples at risk for endogenous antibody interference with high antimicrosomal antibody, anti-TSH receptor antibody and increased rheumatoid factor sub-populations.
Across all controls and between platforms, precision measurements were comparable and varied between 0.7% and 12.8% for TSH, 2.8% and 13% for FT4, 1.8% and 10.5% for FT3 and 3.1% and 16% for T3 assay. Acceptable correlation and reproducibility were found between the three Bayer Immuno 1 platforms at each country's site with all four thyroid panel assays demonstrating r-values of 0.989 to 1.000 and slopes of 0.915 to 1.078. Comparisons between the different platforms showed acceptable correlation for all thyroid panel assays. Specimens containing rheumatoid factor were associated with a significantly increased variation between systems for the FT4 and FT3 assays (p < 0.01). This effect did not appear to be selective for a given platform. For specimens with raised autoimmune antibodies and therefore at risk of assay antibody interference, no variation could be observed between the platforms.
Copyright © 2000 by Walter de Gruyter GmbH & Co. KG
Articles in the same Issue
- Changes of the Coagulation and Fibrinolysis System in Malignancy: Their possible Impact on Future Diagnostic and Therapeutic Procedures
- Laboratory Support of the Clinical Nutrition Service
- A new Method for Fast Haptoglobin Phenotyping and Hemoglobin Binding Capacity Calculation Based on Capillary Zone Electrophoresis
- Apolipoprotein E Polymorphism and Serum Concentration in Alzheimer's Disease in Nine European Centres: the ApoEurope Study
- Association of the Apolipoprotein B Gene Polymorphisms with Cholesterol Levels and Response to Fluvastatin in Brazilian Individuals with High Risk for Coronary Heart Disease
- Antioxidant Status, Erythrocyte Membrane Lipid Peroxidation and Osmotic Fragility in Malignant Lymphoma Patients
- Determination of H+/K+-ATPase Activity in Human Gastric Biopsy Specimens
- European Cerebrospinal Fluid Consensus Group a TeamRoom (Lotus Notes)-Based Communication Network
- Automated Enzymatic Mitochondrial Antibody Assay for the Diagnosis of Primary Biliary Cirrhosis
- Study of IgM Aggregation in Serum of Patients with Macroglobulinemia
- Trace Element Reference Values in Serum Determined by Inductively Coupled Plasma Atomic Emission Spectrometry
- Comparison of Two Different Methods for Measurement of Phenylalanine in Dried Blood Spots
- Anti-β2-Glycoprotein I ELISA: Methodology, Determination of Cut-off Values in 434 Healthy Caucasians and Evaluation of Monoclonal Antibodies as Possible International Standards
- Comparative Multicentre Study of a Panel of Thyroid Tests Using Different Automated Immunoassay Platforms and Specimens at High Risk of Antibody Interference
- A G5569A HFE Gene Polymorphism that Interferes in DNA Tests for Genetic Haemochromatosis: Who Needs to Be Re-tested?
- Evaluation of the Conformity of Human Growth Hormone. Concentrations Measured with the DPC Immulite® and the Nichols® Advantage™ Assays
- Atlas of Atherosclerosis – Progression and Regression. By Herbert C. Stary
- Liver Disease and Laboratory Medicine. By Ian McFarlane, Adrian Bomford and Roy Sherwood
Articles in the same Issue
- Changes of the Coagulation and Fibrinolysis System in Malignancy: Their possible Impact on Future Diagnostic and Therapeutic Procedures
- Laboratory Support of the Clinical Nutrition Service
- A new Method for Fast Haptoglobin Phenotyping and Hemoglobin Binding Capacity Calculation Based on Capillary Zone Electrophoresis
- Apolipoprotein E Polymorphism and Serum Concentration in Alzheimer's Disease in Nine European Centres: the ApoEurope Study
- Association of the Apolipoprotein B Gene Polymorphisms with Cholesterol Levels and Response to Fluvastatin in Brazilian Individuals with High Risk for Coronary Heart Disease
- Antioxidant Status, Erythrocyte Membrane Lipid Peroxidation and Osmotic Fragility in Malignant Lymphoma Patients
- Determination of H+/K+-ATPase Activity in Human Gastric Biopsy Specimens
- European Cerebrospinal Fluid Consensus Group a TeamRoom (Lotus Notes)-Based Communication Network
- Automated Enzymatic Mitochondrial Antibody Assay for the Diagnosis of Primary Biliary Cirrhosis
- Study of IgM Aggregation in Serum of Patients with Macroglobulinemia
- Trace Element Reference Values in Serum Determined by Inductively Coupled Plasma Atomic Emission Spectrometry
- Comparison of Two Different Methods for Measurement of Phenylalanine in Dried Blood Spots
- Anti-β2-Glycoprotein I ELISA: Methodology, Determination of Cut-off Values in 434 Healthy Caucasians and Evaluation of Monoclonal Antibodies as Possible International Standards
- Comparative Multicentre Study of a Panel of Thyroid Tests Using Different Automated Immunoassay Platforms and Specimens at High Risk of Antibody Interference
- A G5569A HFE Gene Polymorphism that Interferes in DNA Tests for Genetic Haemochromatosis: Who Needs to Be Re-tested?
- Evaluation of the Conformity of Human Growth Hormone. Concentrations Measured with the DPC Immulite® and the Nichols® Advantage™ Assays
- Atlas of Atherosclerosis – Progression and Regression. By Herbert C. Stary
- Liver Disease and Laboratory Medicine. By Ian McFarlane, Adrian Bomford and Roy Sherwood
